GABELLI FUNDS LLC - BIOTA PHARMACEUTIALS INC ownership

BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 50 filers reported holding BIOTA PHARMACEUTIALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of BIOTA PHARMACEUTIALS INC
ValueSharesWeighting
Q1 2016$95,000
-4.0%
63,075
+23.3%
0.00%0.0%
Q4 2015$99,000
-2.0%
51,1750.0%0.00%0.0%
Q3 2015$101,000
-4.7%
51,1750.0%0.00%0.0%
Q2 2015$106,000
-10.2%
51,1750.0%0.00%0.0%
Q1 2015$118,000
+2.6%
51,1750.0%0.00%0.0%
Q4 2014$115,000
+42.0%
51,175
+57.0%
0.00%
Q3 2014$81,000
+24.6%
32,594
+43.2%
0.00%
Q2 2014$65,000
-50.4%
22,761
+6.6%
0.00%
-100.0%
Q1 2014$131,000
-17.1%
21,361
-43.3%
0.00%0.0%
Q4 2013$158,000
+0.6%
37,6610.0%0.00%0.0%
Q3 2013$157,000
+20.8%
37,6610.0%0.00%0.0%
Q2 2013$130,00037,6610.00%
Other shareholders
BIOTA PHARMACEUTIALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,486,711$6,764,0000.42%
SENZAR ASSET MANAGEMENT, LLC 1,910,476$3,706,323,0000.41%
TOWERVIEW LLC 160,000$310,0000.16%
BVF INC/IL 350,776$681,0000.12%
GABELLI & Co INVESTMENT ADVISERS, INC. 218,177$423,0000.05%
EAGLE GLOBAL ADVISORS LLC 272,072$528,0000.02%
Spark Investment Management LLC 70,500$136,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 203,170$394,0000.01%
JW Asset Management, LLC 8,611$17,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 147,281$286,0000.01%
View complete list of BIOTA PHARMACEUTIALS INC shareholders